Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

Multimedia

Podcasts
06/04/2019
Jordan Bazinsky, executive vice president and administrative officer for Cotiviti, breaks down various factors impacting innovation, including market trends that he believes are both headwinds and tailwinds to innovation, as well as shares a...
Jordan Bazinsky, executive vice president and administrative officer for Cotiviti, breaks down various factors impacting innovation, including market trends that he believes are both headwinds and tailwinds to innovation, as well as shares a...
Jordan Bazinsky, executive vice...
06/04/2019
First Report Managed Care
Podcasts
04/04/2019
In this first installment of the Great Debates in Pharmacy series, follow along and answer questions as we explore what determines an outstanding pharmacist.
In this first installment of the Great Debates in Pharmacy series, follow along and answer questions as we explore what determines an outstanding pharmacist.
In this first installment of the...
04/04/2019
Pharmacy Learning Network
Podcasts
02/21/2019
Michael Fralick, MD, FRCPC, Brigham and Women’s Hospital, discusses his recent study that examined a medication approved for psuedobulbar affect, which he found was regularly being prescribed to patients with PD and dementia. He explains why...
Michael Fralick, MD, FRCPC, Brigham and Women’s Hospital, discusses his recent study that examined a medication approved for psuedobulbar affect, which he found was regularly being prescribed to patients with PD and dementia. He explains why...
Michael Fralick, MD, FRCPC,...
02/21/2019
Annals of Long-Term Care
Podcasts
02/21/2019
Peter Pitts, former associate commissioner with the FDA and president of the Center for Medicine in the Public Interest, discusses why CBD remains unlawful under FDA regulations to be marketed as a dietary supplement, regardless of whether or...
Peter Pitts, former associate commissioner with the FDA and president of the Center for Medicine in the Public Interest, discusses why CBD remains unlawful under FDA regulations to be marketed as a dietary supplement, regardless of whether or...
Peter Pitts, former associate...
02/21/2019
Pharmacy Learning Network
Podcasts
02/15/2019
Steven Feldman, MD, PhD, professor of dermatology at the Wake Forest School of Medicine, discusses costs associated with psoriasis drugs and focuses specifically on the impact these costs have on insurers.
Steven Feldman, MD, PhD, professor of dermatology at the Wake Forest School of Medicine, discusses costs associated with psoriasis drugs and focuses specifically on the impact these costs have on insurers.
Steven Feldman, MD, PhD,...
02/15/2019
First Report Managed Care
Podcasts
02/14/2019
Nan Li, health outcomes researcher at Janssen, discusses the importance of understanding health care utilization, expenditures, and work productivity among patients with RA with or without comorbidities.
Nan Li, health outcomes researcher at Janssen, discusses the importance of understanding health care utilization, expenditures, and work productivity among patients with RA with or without comorbidities.
Nan Li, health outcomes...
02/14/2019
First Report Managed Care
Podcasts
02/05/2019
In this expert commentary, Steven Lieberman, MD, acting principal deputy under secretary for health at the Veterans Health Administration, explains the history of wait times within the VA and discusses how they have improved in recent years...
In this expert commentary, Steven Lieberman, MD, acting principal deputy under secretary for health at the Veterans Health Administration, explains the history of wait times within the VA and discusses how they have improved in recent years...
In this expert commentary,...
02/05/2019
Veterans Health Today
Podcasts
02/01/2019
Transcript to Lynn Flint's Podcast: Eric: Welcome to the GeriPal Podcast. This is Eric Widera. Alex: This is Alex Smith. Eric: And Alex, I spy someone in our room with us. Alex: We have a frequent guest, who has been a host in the past...
Transcript to Lynn Flint's Podcast: Eric: Welcome to the GeriPal Podcast. This is Eric Widera. Alex: This is Alex Smith. Eric: And Alex, I spy someone in our room with us. Alex: We have a frequent guest, who has been a host in the past...
Transcript to Lynn Flint's...
02/01/2019
Annals of Long-Term Care
Podcasts
01/21/2019
Peter Pitts, former associate commissioner at the US FDA and president of the Center for Medicine in the Public Interest, discusses why the FDA pulled a large quantity of a blood pressure drugs off the market and why it is important to...
Peter Pitts, former associate commissioner at the US FDA and president of the Center for Medicine in the Public Interest, discusses why the FDA pulled a large quantity of a blood pressure drugs off the market and why it is important to...
Peter Pitts, former associate...
01/21/2019
Pharmacy Learning Network
Podcasts
12/13/2018
In this week's GeriPal podcast we talk with Tim Girard, Plumonary Critical Care physician-researcher at the University of Pittsburgh about his study NEJM study of Haloperidol vs. Ziprasidone vs. Placebo for ICU delirium in critically ill...
In this week's GeriPal podcast we talk with Tim Girard, Plumonary Critical Care physician-researcher at the University of Pittsburgh about his study NEJM study of Haloperidol vs. Ziprasidone vs. Placebo for ICU delirium in critically ill...
In this week's GeriPal podcast...
12/13/2018
Annals of Long-Term Care

Advertisement

Advertisement

Advertisement